Clinical Validity and Utility of Genetic Testing in Common Multifactorial Diseases

Author(s):  
Michael Krawczak
2012 ◽  
Vol 16 (6) ◽  
pp. 476-481 ◽  
Author(s):  
Vanessa J. Marshall ◽  
Nnenna Kalu ◽  
John Kwagyan ◽  
Carla Williams ◽  
Robert E. Taylor ◽  
...  

2004 ◽  
Vol 74 (3) ◽  
pp. 588-589 ◽  
Author(s):  
Quanhe Yang ◽  
Muin J. Khoury ◽  
Lorenzo Botto ◽  
J.M. Friedman ◽  
W. Dana Flanders

2019 ◽  
Author(s):  
Marina T. DiStefano ◽  
Sarah E. Hemphill ◽  
Andrea M. Oza ◽  
Rebecca K. Siegert ◽  
Andrew R. Grant ◽  
...  

AbstractPurposeProper interpretation of genomic variants is critical to successful medical decision making based on genetic testing results. A fundamental prerequisite to accurate variant interpretation is the clear understanding of the clinical validity of gene-disease relationships. The Clinical Genome Resource (ClinGen) has developed a semi-quantitative framework to assign clinical validity to gene-disease relationships.MethodsThe ClinGen Hearing Loss Gene Curation Expert Panel (HL GCEP) uses this framework to perform evidence-based curations of genes present on testing panels from 17 clinical laboratories in the Genetic Testing Registry. The HL GCEP curated and reviewed 142 genes and 164 gene-disease pairs, including 105 nonsyndromic and 59 syndromic forms of hearing loss.ResultsThe final outcome included 82 Definitive (50%), 12 Strong (7%), 25 Moderate (15%), 32 Limited (20%), 10 Disputed (6%), and 3 Refuted (2%) classifications. The summary of each curation is date stamped with the HL GCEP approval, is live, and will be kept up-to-date on the ClinGen website (https://search.clinicalgenome.org/kb/gene-validity).ConclusionThis gene curation approach serves to optimize the clinical sensitivity of genetic testing while reducing the rate of uncertain or ambiguous test results caused by the interrogation of genes with insufficient evidence of a disease link.


2004 ◽  
Vol 74 (3) ◽  
pp. 585-588 ◽  
Author(s):  
A. Cecile J.W. Janssens ◽  
M. Carolina Pardo ◽  
Ewout W. Steyerberg ◽  
Cornelia M. van Duijn

2022 ◽  
Vol 20 (8) ◽  
pp. 3120
Author(s):  
E. E. Baranova ◽  
Ksenia Dmitrievna Fedulova ◽  
A. S. Glotov ◽  
V. L. Izhevskaya

Currently, a significant part of research in the fields of human and medical genetics is carried out using tissue samples, genealogical, population, medical and personal data. Their use is of particular relevance in the “genome era”, since only joint analysis of genomic data and health status of the population is crucial for understanding how genes are associated with health and disease. Genetic studies of adults without symptoms of diseases are carried out to obtain data on a possible predisposition to multifactorial diseases, to establish the carrier status of autosomal recessive mutations as part of preconception care and to assess individual sensitivity to drugs. In addition, healthy individuals can be tested to detect an inherited disease at presymptomatic stage. This situation increasingly emphasizes the importance of storing data on genome sequencing or any other patient tests for subsequent data reanalysis, as well as their safety, including biosamples from an individual and one’s family. The review article, based on international experience, summarizes guidelines for genetic testing of healthy individuals. The options for storing biological samples and related data are considered.


Pathology ◽  
2014 ◽  
Vol 46 ◽  
pp. S27-S28 ◽  
Author(s):  
Karin S. Kassahn ◽  
Hamish S. Scott ◽  
Janice M. Fletcher

1983 ◽  
Vol 48 (3) ◽  
pp. 328-329
Author(s):  
Charles B. Koval ◽  
Patricia G. Stelmachowicz
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document